5 Patents
- US121889272025Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Horizon Therapeutics USA, Inc.
0 cites - US119826702024Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Horizon Therapeutics USA, Inc.
0 cites - US116399272023Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Horizon Therapeutics USA, Inc.
0 cites - US115987672023Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Horizon Therapeutics USA, Inc.
0 cites